Skip to main content
Top
Published in: BMC Palliative Care 1/2017

Open Access 01-12-2017 | Research article

Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity

Authors: Yolanda Martínez-Campo, Christian Homedes, Ana Lazaro, Raquel Alarcón, David Campo, Mariona Riera, Raúl Domínguez, Mónica Povedano, Carlos Casasnovas

Published in: BMC Palliative Care | Issue 1/2017

Login to get access

Abstract

Background

Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that dramatically affects patients’ quality of life (QoL) and dignity of life (DoL). We aimed to study the impact of ALS on QoL and DoL and how these evolve throughout the duration of the disease.

Methods

First, we performed an observational, descriptive study of 43 patients with ALS recruited from the ALS unit at our center and compared them with 20 healthy age- and sex-matched controls. Second, we performed a prospective cohort study, following up 23 patients with ALS over 3 months. All participants completed questionnaires about their functional status, QoL, and DoL.

Results

QoL and DoL were significantly worse in the ALS group than in controls (both p < 0.001). During the three-month follow-up in the ALS cohort, statistically significant declines were observed in clinical status and QoL. For clinical status, median scores on the ALS Functional Rating scale changed from 30.95 points at baseline to 27.24 points after 3 months (p = 0.0003). For QoL, median scores on the ALS Assessment Questionnaire changed from 124.19 points at baseline to 131.81 at 3 months (p = 0.0062). However, no significant differences were found between the DoL scores at baseline (48.14 points) and 3 months (45 points) (p-value = 0.12).

Conclusions

ALS is a neurodegenerative disease that affects QoL and DoL alike. We found that clinical status and QoL both deteriorated in patients with ALS as the disease progressed, but that DoL was preserved. However, our findings are limited by small sample sizes. The preservation of DoL may be due to multiple factors, including the therapies provided by the ALS unit. These findings suggest that alongside QoL, DoL may be an important target in the management and care of ALS patients.
Literature
1.
go back to reference Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. Philadelphia: Contemporary Neurology Series, 49, F.A. Davis Company; 1998. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. Philadelphia: Contemporary Neurology Series, 49, F.A. Davis Company; 1998.
2.
go back to reference Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.CrossRefPubMed Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.CrossRefPubMed
4.
go back to reference Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol (Paris). 2016;172(1):37–45.CrossRef Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol (Paris). 2016;172(1):37–45.CrossRef
5.
go back to reference Al-Chalabi A, Leigh PN. Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol. 2000 Aug;13(4):397–405.CrossRefPubMed Al-Chalabi A, Leigh PN. Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol. 2000 Aug;13(4):397–405.CrossRefPubMed
6.
go back to reference Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5–6):310–23.CrossRefPubMedPubMedCentral Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5–6):310–23.CrossRefPubMedPubMedCentral
7.
go back to reference Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J, WFN Research Group On ALS/MND. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5–6):291–2.CrossRefPubMed Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J, WFN Research Group On ALS/MND. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5–6):291–2.CrossRefPubMed
8.
go back to reference Cebarbaum J. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II study group. Arch Neurol. 1996 Feb;53(2):141–7.CrossRef Cebarbaum J. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II study group. Arch Neurol. 1996 Feb;53(2):141–7.CrossRef
9.
go back to reference Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74.CrossRefPubMed Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74.CrossRefPubMed
10.
go back to reference Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis assessment, research, and education database. Ann Neurol. 2009;65:S8–24.CrossRef Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis assessment, research, and education database. Ann Neurol. 2009;65:S8–24.CrossRef
11.
go back to reference Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:33–40.CrossRefPubMed Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:33–40.CrossRefPubMed
12.
go back to reference JJanssens AI, Ruytings M, Al-Chalabi A, Chio A, Hardiman O, Mcdermott CJ, Meyer T, Mora G, Van Damme P, Van Den Berg LH, Vanhaecht K, Winkler AS, Sermeus W, ALS-CARE Consortium. A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5–6):325–36.CrossRef JJanssens AI, Ruytings M, Al-Chalabi A, Chio A, Hardiman O, Mcdermott CJ, Meyer T, Mora G, Van Damme P, Van Den Berg LH, Vanhaecht K, Winkler AS, Sermeus W, ALS-CARE Consortium. A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5–6):325–36.CrossRef
13.
go back to reference Chochinov HM, Johnston W, McClement SE, Hack TF, Dufault B, Enns M, et al. Dignity and distress towards the end of life across four non-cancer populations. PLoS One. 2016;11(1):1–13.CrossRef Chochinov HM, Johnston W, McClement SE, Hack TF, Dufault B, Enns M, et al. Dignity and distress towards the end of life across four non-cancer populations. PLoS One. 2016;11(1):1–13.CrossRef
14.
go back to reference Chen HP, Huang BY, Yi TW, Deng YT, Liu J, Zhang J, Wang YQ, Zhang ZY, Jiang Y. Attitudes of Chinese oncology physicians toward death with dignity. J Palliat Med. 2016 Aug;19(8):874–8.CrossRefPubMedPubMedCentral Chen HP, Huang BY, Yi TW, Deng YT, Liu J, Zhang J, Wang YQ, Zhang ZY, Jiang Y. Attitudes of Chinese oncology physicians toward death with dignity. J Palliat Med. 2016 Aug;19(8):874–8.CrossRefPubMedPubMedCentral
15.
go back to reference Bentley B, O'Connor M, Breen LJ, Kane R. Feasibility, acceptability and potential effectiveness of dignity therapy for family carers of people with motor neurone disease. BMC Palliat Care. 2014;13(1):12.CrossRefPubMedPubMedCentral Bentley B, O'Connor M, Breen LJ, Kane R. Feasibility, acceptability and potential effectiveness of dignity therapy for family carers of people with motor neurone disease. BMC Palliat Care. 2014;13(1):12.CrossRefPubMedPubMedCentral
16.
go back to reference Chochinov HM. Dignity-conserving care-a new model for palliative care: helping the patient feel valued. JAMA. 2002;287(17):2253–60.CrossRefPubMed Chochinov HM. Dignity-conserving care-a new model for palliative care: helping the patient feel valued. JAMA. 2002;287(17):2253–60.CrossRefPubMed
17.
go back to reference Chochinov HM, Hack T, McClement S, Kristjanson L, Harlos M. Dignity in the terminally ill: a developing empirical model. Soc Sci Med. 2002 Feb;54(3):433–43.CrossRefPubMed Chochinov HM, Hack T, McClement S, Kristjanson L, Harlos M. Dignity in the terminally ill: a developing empirical model. Soc Sci Med. 2002 Feb;54(3):433–43.CrossRefPubMed
18.
go back to reference Chochinov HM, Hassard T, McClement S, Hack T, Kristjanson L, et al. The patient dignity inventory: a novel way of measuring dignity related distress in palliative care. J Pain Symptom Manag. 2008;36:559–71.CrossRef Chochinov HM, Hassard T, McClement S, Hack T, Kristjanson L, et al. The patient dignity inventory: a novel way of measuring dignity related distress in palliative care. J Pain Symptom Manag. 2008;36:559–71.CrossRef
19.
go back to reference Chochinov HM, McClement SE, Hack TF, McKeen NA, Rach AM, Gagnon P, et al. The patient dignity inventory: applications in the oncology setting. J Palliat Med. 2012;15(9):998–1005.CrossRefPubMed Chochinov HM, McClement SE, Hack TF, McKeen NA, Rach AM, Gagnon P, et al. The patient dignity inventory: applications in the oncology setting. J Palliat Med. 2012;15(9):998–1005.CrossRefPubMed
20.
go back to reference Lam CL, Lauder IJ. The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Fam Pract. 2000;17(2):159–66.CrossRefPubMed Lam CL, Lauder IJ. The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Fam Pract. 2000;17(2):159–66.CrossRefPubMed
21.
go back to reference Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340–4.CrossRefPubMed Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340–4.CrossRefPubMed
22.
go back to reference Jacobson AM, Braffett B, Cleary P, Gubitosi-Klug R, Larkin M, et al. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life. Diabetes Care. 2013;36(10):3131–8.CrossRefPubMedPubMedCentral Jacobson AM, Braffett B, Cleary P, Gubitosi-Klug R, Larkin M, et al. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life. Diabetes Care. 2013;36(10):3131–8.CrossRefPubMedPubMedCentral
23.
go back to reference Byock IR. Measuring quality of life for patients with terminal illness: the Missoula–VITAS® quality of life index. Palliat Med. 1998;12:231–44.CrossRefPubMed Byock IR. Measuring quality of life for patients with terminal illness: the Missoula–VITAS® quality of life index. Palliat Med. 1998;12:231–44.CrossRefPubMed
24.
go back to reference Hogg KE, Goldstein LJ, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24:625–32.CrossRefPubMed Hogg KE, Goldstein LJ, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24:625–32.CrossRefPubMed
25.
go back to reference Braga AC, Pinto A. Health care management in ALS patients: its influence on quality of life. Home Heal Care Manag Pract. 2015;27(4):201–7.CrossRef Braga AC, Pinto A. Health care management in ALS patients: its influence on quality of life. Home Heal Care Manag Pract. 2015;27(4):201–7.CrossRef
26.
go back to reference Kristjanson LJ, Toye C, Dawson S. New dimensions in palliative care: a palliative approach to neurodegenerative diseases and final illness in older people. Med J Aust. 2003;179(6 Suppl):S41–3.PubMed Kristjanson LJ, Toye C, Dawson S. New dimensions in palliative care: a palliative approach to neurodegenerative diseases and final illness in older people. Med J Aust. 2003;179(6 Suppl):S41–3.PubMed
27.
go back to reference Zamietra K, Lehman EB, Felgoise SH, Walsh SM, Stephens HE, Simmons Z. Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotroph Lateral Scler. 2012;13(1):55–8.CrossRefPubMed Zamietra K, Lehman EB, Felgoise SH, Walsh SM, Stephens HE, Simmons Z. Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotroph Lateral Scler. 2012;13(1):55–8.CrossRefPubMed
28.
go back to reference Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Non-invasive ventilation in ALS: indications and effect on. Quality of life. Neurology. 2003;61:171–7.CrossRefPubMed Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Non-invasive ventilation in ALS: indications and effect on. Quality of life. Neurology. 2003;61:171–7.CrossRefPubMed
Metadata
Title
Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity
Authors
Yolanda Martínez-Campo
Christian Homedes
Ana Lazaro
Raquel Alarcón
David Campo
Mariona Riera
Raúl Domínguez
Mónica Povedano
Carlos Casasnovas
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2017
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-017-0260-6

Other articles of this Issue 1/2017

BMC Palliative Care 1/2017 Go to the issue